Last 12 months
Inside the activity.
2 purchase rows · 48 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 18 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 13 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2021 Filed Feb 3, 2021 23:40 UTC |
Schwartz Robert HarrisPresident and CEO
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007474 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,850 F1 · shares: The performance-based restricted stock units (the "Units") vest upon the Reporting Person's continued service and achievement of certain stock price levels calculated utilizing a four-year compound annual growth rate and based on the average closing bid price per share of the Issuer's common stock measured over a sixty (60) trading-day period. The Reporting Person may vest in a minimum of 25% of the target reported Units and up to a maximum of 350% of the target reported Units based on specified stock price levels. The vesting end measurement date is February 1, 2025, with earlier vesting determination dates upon a change in control of Issuer, the involuntary termination of the Reporting Person or twelve (12) months following the achievement of the maximum stock price level. If after February 1, 2023, the Reporting Person achieves a stock price level, there will be a vesting determination date the earlier of 12 months thereafter or February 1, 2025. Read SEC document |
| January 07, 2021 Filed Jan 8, 2021 23:20 UTC |
Ashe Gena LGeneral Counsel & Secretary
|
GrantStock Option (Right to Buy) · Derivative | 849 | $0.00 Strike: $32.90 | $0.00 |
DisclosureSEC source: 0001209191-21-002814 · doc4.xml · derivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 849 Underlying: Common Stock · 849 shares Expires 2031-01-07 F1 · derivative.exercise_date: The option shares vest and become exercisable in 2 equal annual installments measured from January 7, 2021. Read SEC document |
| January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment |
Ashe Gena LGeneral Counsel & Secretary
|
GrantStock Option (Right to Buy) · Derivative | 0 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003674 · doc4a.xml · derivative · entry 2 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2031-01-07 F2 · derivative.exercise_date: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported. F2 · balance_after: The stock option previously reported for 849 shares granted on January 7, 2021 was reported in error. The award received by the reporting person was an award for RSUs as now reported on Table I and not a stock option award as previously reported. Read SEC document |
| January 07, 2021 Filed Jan 14, 2021 23:27 UTC Amendment |
Ashe Gena LGeneral Counsel & Secretary
|
GrantCommon Stock | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003674 · doc4a.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,555 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest in 2 equal annual installments on January 7, 2022 and January 7, 2023. Read SEC document |
| December 29, 2020 Filed May 3, 2021 20:50 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029650 · doc5.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,050 F1 · kind: These transactions represent gifts or charitable contributions by the Reporting Person. Read SEC document |
| December 29, 2020 Filed May 4, 2021 00:52 UTC |
Schwartz Robert HarrisDirector · President and CEO
|
GiftCommon Stock | 1,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029651 · doc5.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,792 F1 · kind: These transactions represent a charitable contribution by the Reporting Person. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 18:13 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,667 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-20-065071 · doc4.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 31,667 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 18:13 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 31,667 | $40.17 | $1,272,063.39 |
DisclosureSEC source: 0001209191-20-065071 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,250 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $40.00 to $40.81. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 18:13 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 31,667 | $20.00 | $633,340.00 |
DisclosureSEC source: 0001209191-20-065071 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 00:23 UTC |
Guttman-McCabe ChristopherChief Reg & Comm Officer
|
SaleCommon Stock | 1,590 | $29.75 | $47,302.50 |
DisclosureSEC source: 0001209191-20-063906 · doc4.xml · nonDerivative · entry 1 Guttman-McCabe Christopher · CIK 0001828490 · Chief Reg & Comm Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,020 F1 · shares: Represents shares sold pursuant to a 10b-5-1 trading plan adopted by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units granted August 2020. Read SEC document |
| December 01, 2020 Filed Dec 4, 2020 00:32 UTC |
Gangeri ElaineChief Acc Officer, Treasurer
|
SaleCommon Stock | 1,018 | $30.10 | $30,641.80 |
DisclosureSEC source: 0001209191-20-061672 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,298 Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 23:25 UTC |
DANIELS LESLIE BDirector
|
PurchaseCommon Stock | 2,000 | $28.50 | $57,000.00 |
DisclosureSEC source: 0001209191-20-060317 · doc4.xml · nonDerivative · entry 1 DANIELS LESLIE B · CIK 0001052559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,072 Read SEC document |
| November 19, 2020 Filed May 3, 2021 20:50 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
GiftCommon Stock | 12,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029650 · doc5.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,050 F1 · kind: These transactions represent gifts or charitable contributions by the Reporting Person. Read SEC document |
| November 18, 2020 Filed Jun 23, 2021 01:46 UTC |
DANIELS LESLIE BDirector
|
PurchaseCommon Stock | 1,000 | $28.56 | $28,560.00 |
DisclosureSEC source: 0001209191-21-042662 · doc4.xml · nonDerivative · entry 2 DANIELS LESLIE B · CIK 0001052559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,072 Read SEC document |
| November 18, 2020 Filed Jun 23, 2021 01:46 UTC |
DANIELS LESLIE BDirector
|
PurchaseCommon Stock | 1,000 | $29.06 | $29,060.00 |
DisclosureSEC source: 0001209191-21-042662 · doc4.xml · nonDerivative · entry 1 DANIELS LESLIE B · CIK 0001052559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,072 Read SEC document |
| September 08, 2020 Filed Sep 8, 2020 18:14 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 4,635 | $40.18 | $186,225.49 |
DisclosureSEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,250 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $39.92 to $40.85. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 18:14 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 9,715 | $42.30 | $410,916.33 |
DisclosureSEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,885 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.00 to $42.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 3, 2020 22:40 UTC |
Schwartz Robert HarrisPresident and CEO
|
SaleCommon Stock | 6,493 | $42.70 | $277,258.89 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 2 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,850 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted June 2016 and February 2020. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.22 to $42.7034. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 18:14 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
GrantStock Option (Right to Buy) · Derivative | 26,464 | $0.00 Strike: $46.85 | $0.00 |
DisclosureSEC source: 0001209191-20-049778 · doc4.xml · derivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,464 Underlying: Common Stock · 26,464 shares Expires 2025-08-29 F5 · balance_after: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the stock option. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 18:14 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
GrantCommon Stock | 26,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049778 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,600 F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| September 02, 2020 Filed Sep 2, 2020 22:22 UTC |
Gray TimothyChief Financial Officer
|
SaleCommon Stock | 3,338 | $42.85 | $143,034.30 |
DisclosureSEC source: 0001209191-20-049245 · doc4.xml · nonDerivative · entry 2 Gray Timothy · CIK 0001629762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,124 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.62 to $43.255. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:20 UTC |
PRATT GREGORY ADirector
|
GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049540 · doc4.xml · nonDerivative · entry 1 PRATT GREGORY A · CIK 0001094960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,301 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:16 UTC |
DANIELS LESLIE BDirector
|
GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049537 · doc4.xml · nonDerivative · entry 1 DANIELS LESLIE B · CIK 0001052559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,072 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 18:17 UTC |
Haller GregDirector
|
GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049538 · doc4.xml · nonDerivative · entry 1 Haller Greg · CIK 0001756620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,776 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:14 UTC |
Akhavan HamidDirector
|
GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049536 · doc4.xml · nonDerivative · entry 1 Akhavan Hamid · CIK 0001295252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,072 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 18:19 UTC |
MCALLISTER SINGLETON BDirector
|
GrantCommon Stock | 2,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049539 · doc4.xml · nonDerivative · entry 1 MCALLISTER SINGLETON B · CIK 0001209079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,908 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 18:21 UTC |
SALEH PAUL NDirector
|
GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049541 · doc4.xml · nonDerivative · entry 1 SALEH PAUL N · CIK 0001196630 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,537 F1 · shares: The restricted stock vests in full on the earlier of (i) September 2, 2021 or (ii) immediately prior to commencement of the Issuer's next annual stockholder meeting; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:40 UTC |
Schwartz Robert HarrisPresident and CEO
|
GrantStock Option (Right to Buy) · Derivative | 7,318 | $0.00 Strike: $46.85 | $0.00 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · derivative · entry 3 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,318 Underlying: Common Stock · 7,318 shares Expires 2025-08-29 F4 · balance_after: On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported stock option. Read SEC document |
| September 02, 2020 Filed Sep 3, 2020 22:40 UTC |
Schwartz Robert HarrisPresident and CEO
|
GrantCommon Stock | 10,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049552 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,343 F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 18:19 UTC |
MCAULEY BRIANDirector · Chairman Emeritus
|
SaleCommon Stock | 3,246 | $43.38 | $140,812.78 |
DisclosureSEC source: 0001209191-20-049244 · doc4.xml · nonDerivative · entry 2 MCAULEY BRIAN · CIK 0001014804 · Director · Chairman Emeritus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,840 F2 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.38 to $43.495. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 22:22 UTC |
Gray TimothyChief Financial Officer
|
GrantCommon Stock | 5,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049245 · doc4.xml · nonDerivative · entry 1 Gray Timothy · CIK 0001629762 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,462 F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 18:19 UTC |
MCAULEY BRIANDirector · Chairman Emeritus
|
GrantCommon Stock | 5,784 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049244 · doc4.xml · nonDerivative · entry 1 MCAULEY BRIAN · CIK 0001014804 · Director · Chairman Emeritus 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,086 F1 · shares: On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 21:30 UTC |
Ashe Gena LGeneral Counsel & Secretary
|
SaleCommon Stock | 493 | $44.80 | $22,086.65 |
DisclosureSEC source: 0001209191-20-048552 · doc4.xml · nonDerivative · entry 1 Ashe Gena L · CIK 0001669943 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,706 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted July 2019. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $44.88. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 21:31 UTC |
Gangeri ElaineChief Acc Officer, Asst Sect
|
SaleCommon Stock | 1,641 | $44.80 | $73,518.93 |
DisclosureSEC source: 0001209191-20-048553 · doc4.xml · nonDerivative · entry 1 Gangeri Elaine · CIK 0001782270 · Chief Acc Officer, Asst Sect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,316 F1 · shares: Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and July 2019. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.80 to $45.16. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 19, 2020 Filed Aug 21, 2020 00:13 UTC |
Schwartz Robert HarrisPresident and CEO
|
SaleCommon Stock | 409 | $47.03 | $19,235.68 |
DisclosureSEC source: 0001209191-20-047841 · doc4.xml · nonDerivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,215 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $47.00 to $47.15. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:23 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,030 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047649 · doc4.xml · derivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 3,030 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:23 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 3,030 | $44.76 | $135,625.83 |
DisclosureSEC source: 0001209191-20-047649 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,591 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the exercise of stock options. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.52 to $45.11. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 20:23 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 3,030 | $20.00 | $60,600.00 |
DisclosureSEC source: 0001209191-20-047649 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,162 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · derivative · entry 9 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,030 Underlying: Common Stock · 8,162 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| August 17, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 8,162 | $44.69 | $364,735.29 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 7 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,591 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options. F6 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.28 to $45.19. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 8,162 | $20.00 | $163,240.00 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 6 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,808 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · derivative · entry 8 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,192 Underlying: Common Stock · 8,808 shares Expires 2024-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option shares are fully vested. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 2,775 | $45.21 | $125,460.53 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 5 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,591 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options. F5 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $45.00 to $45.48. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 6,572 | $44.49 | $292,401.42 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 4 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,366 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options. F4 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.98 to $44.92. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
Exercise / conversionCommon Stock | 8,808 | $20.00 | $176,160.00 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 3 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 200 | $44.93 | $8,985.00 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 2 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,130 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options. F3 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $44.92 to $44.93. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:06 UTC |
OBRIEN MORGAN EDirector · Executive Chairman
|
SaleCommon Stock | 7,835 | $44.48 | $348,477.30 |
DisclosureSEC source: 0001209191-20-046988 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,330 F1 · kind: The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and includes the sale of shares in order to cover tax liabilities in connection with the vesting of restricted stock units and the exercise of stock options. F2 · price: This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $43.90 to $44.90. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 19:18 UTC |
OBRIEN MORGAN EDirector · Chief Executive Officer
|
GrantCommon Stock | 40,065 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-039181 · doc4.xml · nonDerivative · entry 1 OBRIEN MORGAN E · CIK 0000937846 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,165 F1 · shares: Represents the issuance of restricted stock units (the "RSUs"). The RSUs will vest in full on July 1, 2021. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 23:17 UTC |
PRATT GREGORY ADirector
|
GrantCommon Stock | 229 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-039180 · doc4.xml · nonDerivative · entry 1 PRATT GREGORY A · CIK 0001094960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229 F1 · shares: The restricted stock vests in full on August 6, 2020; provided, however, that if the vesting would otherwise occur on a date that is closed for trading under the Issuer's Insider Trading Policy, the vesting shall be automatically deemed to occur on the next trading day on which the sale of shares of common stock by the Reporting Person in the open market would be permitted under the Issuer's Insider Trading Policy. Read SEC document |
| June 24, 2020 Filed Jun 26, 2020 23:19 UTC |
Schwartz Robert HarrisPresident and COO
|
GrantStock Option (Right to Buy) · Derivative | 60,558 | $0.00 Strike: $49.92 | $0.00 |
DisclosureSEC source: 0001209191-20-039182 · doc4.xml · derivative · entry 1 Schwartz Robert Harris · CIK 0001654170 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,558 Underlying: Common Stock · 60,558 shares Expires 2030-06-24 F1 · derivative.exercise_date: 25% of the option shares vest and become exercisable on July 1, 2021 with the remaining shares vesting in 3 equal annual installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.